MEDIHALER-ISO Drug Patent Profile
✉ Email this page to a colleague
When do Medihaler-iso patents expire, and when can generic versions of Medihaler-iso launch?
Medihaler-iso is a drug marketed by 3M and is included in one NDA.
The generic ingredient in MEDIHALER-ISO is isoproterenol sulfate. There are seventeen drug master file entries for this compound. Additional details are available on the isoproterenol sulfate profile page.
Summary for MEDIHALER-ISO
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 33 |
Patent Applications: | 10 |
Formulation / Manufacturing: | see details |
DailyMed Link: | MEDIHALER-ISO at DailyMed |
US Patents and Regulatory Information for MEDIHALER-ISO
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3m | MEDIHALER-ISO | isoproterenol sulfate | AEROSOL, METERED;INHALATION | 010375-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |